UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020687
Receipt number R000023872
Scientific Title Effects of Passive Muscle Relaxation in Cancer Patients
Date of disclosure of the study information 2016/02/15
Last modified on 2023/07/28 09:14:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Passive Muscle Relaxation in Cancer Patients

Acronym

Effects of Passive Muscle Relaxation in Cancer Patients

Scientific Title

Effects of Passive Muscle Relaxation in Cancer Patients

Scientific Title:Acronym

Effects of Passive Muscle Relaxation in Cancer Patients

Region

Japan


Condition

Condition

cancer patients

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to effects of passive muscle relaxation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood pressure Pulse Salivary amylaze,
one day,three days

Key secondary outcomes

Interview


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

passive muscle relaxation,three days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

It is announcing cancer It is stable physical, mental

Key exclusion criteria

It is not stable physical, mental

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yuka
Middle name
Last name Kondo

Organization

Gunma University

Division name

Graduate school of health science

Zip code

371-8514

Address

3-39-22 Showa-machi Maebashi Gunma

TEL

027-220-7111

Email

yukondo@gunma-uac.jp


Public contact

Name of contact person

1st name Yuka
Middle name
Last name Kondo

Organization

Gunma University

Division name

Graduate school of health science

Zip code

371-8514

Address

Showa-machi, Maebashi Gunma

TEL

027-220-7111

Homepage URL


Email

yukondo@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University

Institute

Department

Personal name



Funding Source

Organization

Gunma University

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University

Address

Showa-machi,Maebashi,Gunma

Tel

0272207111

Email

yukondo@gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

群馬大学(Gunma University)


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 15 Day

Date of IRB

2019 Year 04 Month 18 Day

Anticipated trial start date

2019 Year 04 Month 18 Day

Last follow-up date

2023 Year 07 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 01 Month 21 Day

Last modified on

2023 Year 07 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023872